Introduction to reactive oxygen species and their pathophysiology
Small amounts of reactive oxygen species (ROS ) are constantly produced in aerobic metabolism and have important roles in normal cell physiology e.g. signal transduction pathways. However, in pathophysiological conditions with increased levels of ROS, these molecules become relevant factors in the initiation and amplification of deleterious processes observed in inflammation, oncogenesis, and degenerative diseases [1, 2] .
ROS are products of the partial reduction of oxygen Fig. 1 . Major reactive oxygen species. and can be generated by enzymatic and non-enzymatic reactions within cells and at the cell membrane [3, 4] . Enzymes that generate ROS are termed oxidative on the availability of the free metal ions Fe2+ or Cu+, enzymes ( Table 1) [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Major ROS are depicted in are the most reactive of the ROS [17] . Several defence Figure 1 , which also shows the important reactions mechanisms exist to decrease the concentration of and catalysts involved. Hypochlorous acid produced ROS. Superoxide dismutases (SODs) catalyse the disby myeloperoxidase and hydroxyl radical (OHV ), mutation of superoxide anion to hydrogen peroxide which evolves from non-enzymatic reactions dependent (H 2 O 2 ), which is further degraded by glutathione peroxidases and catalase ( Table 1) [18] . Besides these antioxidative enzymes, metal-binding proteins such as 
ROS in glomerular disease
be involved as a source of ROS as suggested by increased xanthine oxidase activity in renal homogenAnimal experiments have provided ample evidence that ates of nephrotic animals and by a significant reduction ROS play a major role in many glomerular diseases of proteinuria after inhibition of the enzyme [35] . (see Table 2 ). Most of this evidence has been obtained Renal activities of antioxidative enzymes remained indirectly by the detection of products of lipid peroxessentially unchanged in adriamycin nephrosis [36] [37] [38] [39] [40] . idation in renal tissues and by the demonstration of protective effects of administered antioxidants. This short review will only focus on results of direct exam-
Equivalent to mesangioproliferative GN
Anti-Thy 1 nephritis in rats is an immune complex GN with pronounced mesangial cell proliferation after an initial phase of mesangial cell death and lysis. As early as 2 h after administration of anti-Thy 1 immunoglobulin, glomerular ROS (predominantly H 2 O 2 ) were increased, reaching a peak after 24 h [41] . In parallel with these biochemical results, histochemical analyses located increased formation of H 2 O 2 in the leukocytes that had infiltrated the glomeruli [42] . As glomerular NAD(P)H oxidase activities were elevated at the same time, activation of leukocyte NADPH oxidase may be the major cause of increased glomerular ROS in this have further contributed to increased glomerular in leukocytes isolated from diseased kidneys [47] .
Similar results have been obtained in rats by histochem-ROS [41] .
In contrast to these observations in the acute phase istry, demonstrating increased ROS generation in the leukocytes that had infiltrated the glomeruli [42] . of nephritis, ROS did not seem to participate in the glomerular scarring and tubulointerstitial fibrosis in a Although leukocyte NADPH oxidase may be the likely source of ROS, no studies exist which systematically chronic model of anti-Thy 1 nephritis. However, this changed dramatically in the presence of concomitant examine the relative contribution of NADPH oxidase, myeloperoxidase, and other potentially important hyperlipidaemia, which is regarded as a progression factor in renal disease in patients and experimental oxidases of leukocytes in this model. With regard to the antioxidative enzymes, activities of SOD, catalase, animals. In the animals with chronic nephritis, hyperlipidaemia induced a rise in ROS in glomeruli and and glutathione peroxidases decreased in renal tissues in the course of antibasement membrane GN in rats cortical tubulointerstitium. This increase in ROS could be associated with a higher incidence of glomerulo- [46 ] . sclerosis and mostly of tubular atrophy and interstitial fibrosis. XDH/XO apparently was the major oxidative
Lessons from the animal studies and applications to enzyme responsible for increased ROS in glomeruli human glomerular disease and tubulointerstitium, as demonstrated by increased xanthine oxidase activity and elevated XDH/XO mRNA and protein levels in renal tissues. With regard From experimental observations it is becoming increasingly evident that oxidative injury in glomerular disease to the antioxidant defence, glomerular and tubulointerstitial antioxidative enzymes remained essentially may result primarily from the induction of specific oxidative enzymes in resident glomerular cells and in unchanged [43] . Recent unpublished results of our group imply that XDH/XO may be critically involved leukocytes infiltrating the kidney. In contrast to in vitro observations in cultured glomerular cells [48] , in early processes of hyperlipidaemia-induced progression of renal disease as inhibition of xanthine oxidase glomerular antioxidative enzyme expression appears to be decreased rather than induced in response to prevented the early influx of monocytes into the tubulointerstitium in animals with hyperlipidaemia (Gwinner increased ROS in most glomerular disease models, thus further contributing to the oxidative burden. et al., unpublished data).
However, data are still fragmentary with regard to the analysis of different ROS and their temporal profile
Equivalent to membranous GN
during the course of experimental glomerular diseases. Ultrastructural localization of increased ROS synthesis Active and passive Heymann nephritis ( HN ) is induced and altered oxidative and antioxidative enzyme expresby a complement-dependent immune reaction with sion within the glomerulus has been incomplete. The components of the renal brush border, including mega-mechanisms leading to the changes in oxidative and lin and an associated protein RAP, and is regarded as antioxidative enzyme expression are largely unknown. an experimental equivalent to human membranous The effect of locally increased ROS on cellular signal-GN. In the passive variant of HN, increased H 2 O 2 ling events including induction of redox-sensitive could be demonstrated in the glomerular basement pathways and the ensuing expression of mediators of membrane and glomerular epithelial cells by histo-glomerular inflammation and fibrosis awaits further chemistry. This was associated with the appearance of exploration in the in vivo models of glomerular disease. cytochrome b 558
, a critical component of NADPH Such detailed analyses will be necessary to develop oxidase, in glomerular epithelial cells, with a maximum rational and specific therapeutic strategies. 7 days after induction of nephritis [44] .
Although experimental studies have shed some light Another oxidative enzyme involved in passive HN on the potential mechanisms involved in oxidative is xanthine oxidase. Increased glomerular activity of glomerular injury, a crucial question is whether the this enzyme was observed as early as one day after same mechanisms are active in human GN. Hitherto, induction of nephritis, together with an increase in data are lacking to answer this question. Measurement glomerular VO− 2 levels. Inhibition of xanthine oxidase of ROS in glomeruli of patients with GN has not been decreased glomerular VO− 2 and proteinuria in nephritic performed. The increased generation of VO− 2 in blood animals, thus confirming an important role of this leukocytes of patients with pauci-immune-complex GN oxidative enzyme [45] . In addition to increased genera-that are positive for antineutrophilic cytoplasmic antition of ROS, decreased degradation of ROS may bodies, may be taken as indirect evidence that leukocontribute to glomerular oxidative injury in passive cytes in necrotizing glomeruli could cause injury by HN as antioxidative enzyme activities declined moder-ROS [49] . Also, the oxidative enzymes involved in ately in renal tissues in the course of nephritis [46 ] . increased glomerular ROS generation have not been identified in human GN. With regard to antioxidative
Equivalent to focal segmental necrotizing GN
enzymes, immunhistochemical studies in different forms of GN indicated increased glomerular expression of SODs and catalase, predominantly in patients with In antibasement membrane GN in rabbits, an increased synthesis of VO− 2 , H 2 O 2 , and OHV has been observed IgA nephropathy and lupus nephritis [50] . However,
of the metal chelator desferrioxamine would be limited nephropathy, other studies reported strongest expression of Cu,Zn-SOD and glutathione peroxidase pre-by unwanted effects including anaemia. The vitamins C and E and the sulph-hydryl compound acetylcysteine dominantly in epithelial cells of glomeruli with minor disease involvement [51] [52] [53] .
have been proposed as ROS scavengers in human GN [64] [65] [66] . To date, only preliminary data are available that indicate a beneficial effect of vitamin E on pro-
Therapeutic modulation of oxidative injury in
teinuria in focal segmental glomerulosclerosis [65] and human GN of the antioxidant probucol on proteinuria in membranous GN [67] . Besides these well-defined ROS Strategies to reduce or prevent oxidative glomerular scavengers some clinically established drugs have injury may be realized in two different ways, by inhibi-shown scavenger properties such as captopril, carvetion of increased ROS generation and by enhanced dilol, and calcium antagonists [68] [69] [70] . However, it is degradation of ROS and oxidatively modified cellular unknown, whether this effect plays a significant role in components.
the prevention of oxidative injury in GN.
(iii) Several stimuli have been reported to induce the expression of intrinsic cellular antioxidative
Inhibition of increased ROS generation
enzymes. However, only a few of these stimuli may be of clinical value. For instance, the induction of manInhibition of increased ROS generation may be consid-ganese SOD by interleukin 1, tumour necrosis factor, ered as a relatively specific approach but a prerequisite and endotoxin [71, 72] is associated with an unwanted is that the responsible oxidative enzyme(s) or cata-increase in ROS generation. ACE inhibitors induce lyst(s) have been identified. Clinically available SOD, catalase, and glutathione peroxidase activities in inhibitors of xanthine oxidase include allopurinol, oxy-renal tissues of rodents [73] [74] [75] , and their therapeutic purinol, amflutizole [54] , and tenidap [55] . Yet, their efficacy in human glomerular disease may be explained, therapeutic efficacy has not been examined in human in part, by this effect. An induction of glomerular GN. Specific inhibitors of NAD(P)H oxidases are not antioxidative enzymes has been also shown after stercurrently available for clinical use. Inhibitors of oid administration to rats [33] ; however, as steroids angiotensin II converting enzyme (ACE inhibitors) can induce the expression of XDH/XO [76 ] the net and angiotensin II receptor antagonists may exert some effect on the glomerular oxidative-antioxidative balinhibitory effects on NADPH oxidase as angiotensin II ance remains undetermined. Administration of metal increases NADPH oxidase activity [56, 57] . The thera-cofactors (selenium, manganese, copper, zinc) of antipeutic potential of certain phosphodiesterase inhibitors oxidative enzymes has been suggested in the therapy which may reduce the activation of NADPH oxidase of renal disease, because lack of these factors may in leukocytes [58] and glomerular cells [59] has not exacerbate oxidative injury [64] . It is unknown whether been examined in human GN.
supplementation with these factors sufficiently increases antioxidative enzyme activities; the risk of
Enhanced degradation of ROS
intoxication has certainly to be considered. With regard to therapies aiming at enhanced degradation of ROS some general concerns need to be Several substances can facilitate the enhanced degradation of ROS and partly, of oxidatively modified com-raised. The coordinate decomposition of VO− 2 , H 2 O 2 , and OHVmay require the use of more than one antioxponents: (i) antioxidative enzymes or low-molecular mimics of antioxidative enzymes which catalyse the idative substance. Yet certain combinations of antioxidants have shown pro-oxidant effects [77] . The ROS degradation of ROS, (ii) scavengers that combine with ROS and oxidatively modified components, thereby scavenger vitamin E can turn into a pro-oxidant if vitamin C is not present in sufficiently high concentraneutralizing their oxidative potential, and (iii) stimuli that increase the expression of intrinsic antioxidative tion [22] . Another concern is whether the antioxidative substance is capable of reaching the compartment enzymes.
(i) SOD has been used in preservation solutions in where increased concentrations of ROS are present. Lastly, reduction of ROS below a physiological range renal transplantation, resulting in improved long-term function of allografts [60] . In GN, the efficacy of in certain cell organelles and compartments may disturb the oxidative metabolism necessary for coordinate antioxidative enzymes has not been evaluated. Arguments against therapy with antioxidative enzymes physiological gene transcription and other cell functions. The rational therapy of oxidative injury in GN are the necessity of parenteral administration and the lack of intracellular uptake. Low-molecular mimics may therefore prove to be quite difficult and will only succeed when an integration of therapeutic antioxidant with SOD-and glutathione peroxidase-like activity are capable to penetrate cell membranes [61] [62] [63] and may strategies is achieved into the complex interaction of intra-and extracellular antioxidative-oxidative be therefore an attractive alternative to be tested in human GN.
mechanisms. 
